CJMB

Acquisition includes interests across 377 producing wells, approximately 150 BOE/day of current net production, and 27 additional wells in process, with $48 million of proved PV-10 and an illustrative 21% unlevered cash return at $75 WTI 1

Weigman brings 14 years of Williston Basin experience, including nine years at Northern Oil and Gas, and has sourced potential acquisition opportunities across more than 900 wells The appointment will reunite Weigman with Callan Power President Mike Reger, with whom he worked for nearly a decade at Northern Oil and Gas SPRING BRANCH, Texas, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Callan JMB, Inc. (Nasdaq: CJMB) (“Callan JMB” or the “Company”), a diversified company focused on logistics, emergency preparedness, and critical infrastructure, today announced that Callan Power will designate Andy Weigman as Senior Vice President of Land and Acquisitions upon closing of the previously announced asset acquisition from Reger Oil, Inc. Mr. Weigman will be responsible for Callan Power's s oil and gas land, operations, and acquisition functions.

Mr. Reger brings proven public-company, capital-markets, and energy-sector leadership to advance Callan Power's domestic manufacturing and critical electrical-infrastructure strategy

Program projected to generate approximately $252 million in cumulative net operating cash flow 23-well Red River drilling program forecast to achieve positive operating cash flow in its first year of drilling and generate approximately $42 million in annual net operating cash flow by 2029 SPRING BRANCH, Texas and Wayzata, Minn., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), a diversified company focused on logistics, emergency preparedness and critical infrastructure, today announced that Callan Power LLC (“Callan Power”), a wholly owned subsidiary of Callan JMB, has entered into a definitive agreement to acquire certain oil and gas assets from Reger Oil, Inc. (“Reger Oil”) related to the development of the Williston Basin energy reserves.

SPRING BRANCH, Texas, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (“Callan JMB” or the “Company”) (Nasdaq: CJMB) a diversified company focused on logistics, emergency preparedness and critical infrastructure, today announced that on August 14, 2026, it received written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”). The matter is now closed.

Company builds on its history of supporting Chicago's preparedness operations during major public events and periods of heightened citywide activity

Agreement reinforces the Atlas Complex strategy while expanding Callan JMB's recurring infrastructure services business through a 60% participation in enterprise revenue. The enterprise's underlying business plan contemplates annual revenue of between $12 million and $25 million within seven years under its base-case scenario.

This new landmark project is forecast to ultimately generate estimated annual gross revenues of $500 million for the partnership Callan JMB is entitled to receive a 21% participation in the venture, which could represent approximately $105 million in revenue for the first year and over $400 million in revenues over the five-year agreement The next phase of the project is being initiated with the development of the Marion 9 Biomanufacturing Center at the Atlas Complex by Callan JMB in Marion, Alabama MARION, Ala., July 29, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced breaking ground at the Atlas Complex representing the completion of an important strategic partnership with Alabama State University (“ASU”) to support the development of a significant integrated pharmaceutical manufacturing ecosystem designed to strengthen the United States (U.S.) domestic pharmaceutical production, enhance U.S. supply chain resilience, and improve national medical preparedness.

Management believes the initiative could represent a potential $414 million five-year revenue opportunity for Callan JMB while helping establish a next-generation pharmaceutical manufacturing ecosystem in the United States.

Strategic partnership integrates higher education, industry, and workforce development to accelerate pharmaceutical onshoring and strengthen domestic supply chains